EFFORT Further Extension Study

NCT02826070 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Telbivudine
DRUG: Adefovir dipivoxil
OTHER: off-treatment follow-up

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]